| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | AMGEN INC | REESE DAVID M | EVP & Chief Technology Officer | May 05, 2024 | Option Exercise | $311.29 | 633 | 197,047 | 58,693 | May 07, 2024, 08:37 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP & Chief Technology Officer | May 02, 2024 | Option Exercise | $277.37 | 650 | 180,290 | 59,326 | May 03, 2024, 07:24 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP & Chief Technology Officer | Apr 30, 2024 | Option Exercise | $276.38 | 690 | 190,702 | 59,976 | May 01, 2024, 07:54 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP & Chief Technology Officer | Mar 18, 2024 | Option Exercise | $268.87 | 6,202 | 1,667,532 | 60,666 | Mar 20, 2024, 08:11 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 05, 2023 | Option Exercise | $231.89 | 594 | 137,743 | 54,114 | May 09, 2023, 07:24 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 03, 2023 | Option Exercise | $235.97 | 819 | 193,259 | 54,708 | May 04, 2023, 08:32 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Apr 30, 2023 | Option Exercise | $239.74 | 666 | 159,667 | 51,713 | May 02, 2023, 08:28 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Mar 17, 2023 | Option Exercise | $234.57 | 3,978 | 933,119 | 52,379 | Mar 20, 2023, 07:14 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Nov 02, 2022 | Option Exercise | $272.06 | 2,440 | 663,826 | 48,136 | Nov 03, 2022, 09:38 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 05, 2022 | Option Exercise | $236.10 | 575 | 135,758 | 50,307 | May 09, 2022, 07:12 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 03, 2022 | Option Exercise | $230.92 | 770 | 177,808 | 50,882 | May 04, 2022, 08:07 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Apr 27, 2022 | Option Exercise | $249.87 | 184 | 45,976 | 47,755 | Apr 29, 2022, 06:47 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Mar 18, 2022 | Option Exercise | $235.86 | 4,995 | 1,178,121 | 47,939 | Mar 22, 2022, 05:47 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Nov 02, 2021 | Option Exercise | $209.74 | 2,192 | 459,750 | 42,593 | Nov 03, 2021, 07:27 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 01, 2021 | Option Exercise | $239.64 | 1,109 | 265,761 | 45,217 | May 04, 2021, 07:41 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 03, 2021 | Option Exercise | $239.64 | 745 | 178,532 | 44,472 | May 04, 2021, 07:41 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Apr 27, 2021 | Option Exercise | $255.52 | 174 | 44,460 | 42,320 | Apr 28, 2021, 08:17 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Mar 19, 2021 | Option Exercise | $244.42 | 1,401 | 342,432 | 42,494 | Mar 22, 2021, 06:34 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Feb 16, 2021 | Option Exercise | $237.21 | 1,147 | 272,080 | 40,912 | Feb 16, 2021, 08:59 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Feb 16, 2021 | Option Exercise | $54.69 | 2,300 | 125,787 | 42,059 | Feb 16, 2021, 08:59 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Nov 02, 2020 | Option Exercise | $216.94 | 2,125 | 460,998 | 39,619 | Nov 04, 2020, 07:06 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 03, 2020 | Option Exercise | $230.98 | 185 | 42,731 | 37,939 | May 05, 2020, 07:57 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 01, 2020 | Option Exercise | $239.22 | 1,046 | 250,224 | 38,124 | May 05, 2020, 07:57 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Apr 27, 2020 | Option Exercise | $236.28 | 168 | 39,695 | 39,170 | Apr 29, 2020, 07:04 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Mar 20, 2020 | Option Exercise | $198.76 | 1,855 | 368,700 | 39,338 | Mar 24, 2020, 06:09 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Mar 09, 2020 | Option Exercise | $210.65 | 780 | 164,307 | 40,985 | Mar 10, 2020, 09:12 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Mar 09, 2020 | Option Exercise | $58.43 | 1,480 | 86,476 | 41,765 | Mar 10, 2020, 09:12 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 03, 2019 | Option Exercise | $176.50 | 174 | 30,711 | 31,564 | May 07, 2019, 07:06 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | May 01, 2019 | Option Exercise | $179.32 | 1,014 | 181,834 | 32,859 | May 03, 2019, 05:54 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Mar 22, 2019 | Option Exercise | $191.89 | 1,769 | 339,453 | 32,752 | Mar 25, 2019, 07:41 PM | |
| AMGN | AMGEN INC | REESE DAVID M | EVP, Research and Development | Jan 30, 2019 | Option Exercise | $192.11 | 115 | 22,093 | 30,648 | Feb 01, 2019, 06:25 PM |
Menu